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Introduction
Influenza antiviral resistance monitoring is now a required activity for National 
Influenza Centres (NICs), since the introduction of neuraminidase inhibitors 
(NAI) in 1999. With the availability and wider use of NAI and the stockpiling of 
antivirals for use during an influenza pandemic, continuous monitoring of the 
development of antiviral resistance to both NAI drugs and previously existing 
adamantane drugs (M2 channel inhibitors) has become increasingly important.
Conclusion
A web-based facility for collection, analysis and dissemination of 
influenza antiviral susceptibility data was successfully implemented. Its 
usefulness has been fully validated by the events of the 2007/2008 
winter season when the emergence of high levels of oseltamivir
resistant A(H1N1) viruses was first demonstrated in Europe and the 
database was the key tool used at European and global level for 
accurate dissemination of data.
Methods
In Europe, the EU funded EISS and VIRGIL projects aim at influenza antiviral 
susceptibility monitoring coordinated with existing influenza surveillance 
activities and transfer of knowledge and expertise to NICs in Europe. To collect 
the antiviral susceptibility data and linked patient demographic and clinical data 
in a standardised and comprehensive way, a web-based database with online 
data analysis facilities was developed using phpMyAdmin.
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Processing of data outside the website: 
Map presenting distribution and proportion oseltamivir
resistant A(H1N1) across Europe.
Monthly trend proportion oseltamivir resistant A(H1N1) for 
Europe.
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